Activity of axitinib in progressive advanced solitary fibrous tumour: Results from an exploratory, investigator-driven phase 2 clinical study.
Sign Up to like & getrecommendations! Published in 2019 at "European journal of cancer"
DOI: 10.1016/j.ejca.2018.10.024
Abstract: BACKGROUND To explore the activity of axitinib in advanced solitary fibrous tumour (SFT). PATIENTS AND METHODS In this investigator-driven phase II study on axitinib in advanced and progressive SFT, patients received axitinib, 5 mg bis in… read more here.
Keywords: activity axitinib; response; study; sft ... See more keywords